Peter Kolchinsky

Insider Reports History

Reporting-owner location: Boston, MA
Latest reporting-owner signature: /s/ Matthew Hammond as Attorney-in-Fact
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Peter Kolchinsky

Form 4 holding Director, 10%+ Owner

Forma Therapeutics Holdings, Inc.

Security class: Common Stock
Shares / value: 9,011,651
Estimated value: $45,508,838
Report date: 17 Jun 2021
Price: $5.05
Ownership: Indirect

Form 4 holding Chief Executive Officer, Director

Therapeutics Acquisition Corp.

Security class: Common Stock
Shares / value: 1,098,318
Estimated value: $13,674,059
Report date: 29 Jun 2021
Price: $12.45
Ownership: Indirect

Form 4 holding Director, 10%+ Owner

Forma Therapeutics Holdings, Inc.

Security class: Common Stock
Shares / value: 2,750
Estimated value: $13,888
Report date: 17 Jun 2021
Price: $5.05
Ownership: Direct

Form 4 holding Director, 10%+ Owner

Forma Therapeutics Holdings, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 8,375
Estimated value
Report date: 17 Jun 2021
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Peter Kolchinsky

4

Therapeutics Acquisition Corp.

Report period: 29 Jun 2021
Transactions: 1
Transaction value: +$2,091,000
Accepted by SEC: 30 Jun 2021, 16:31
Role: Chief Executive Officer, Director
Next action: Open filing details

4

Therapeutics Acquisition Corp.

Report period: 24 Jun 2021
Transactions: 1
Transaction value: +$8,892,180
Accepted by SEC: 24 Jun 2021, 19:08
Role: Chief Executive Officer, Director
Next action: Open filing details

4

Forma Therapeutics Holdings, Inc.

Report period: 17 Jun 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 21 Jun 2021, 19:01
Role: Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .